TCGAnalyzeR:一种在线泛癌工具,用于对癌症患者的分子和临床数据进行综合可视化,用于队列和相关基因发现
Talip Zengin1, Başak Abak Masud2, Tuğba Önal-Süzek2
1Department of Molecular Biology and Genetics, Mugla Sitki Kocman University, Mugla 48000, Türkiye.
Cancers
|January 23, 2024
概括
TCGAnalyzeR是一个免费的网络应用程序,集成和可视化癌症基因组图谱 (TCGA) 多omics数据. 它帮助临床医生和生物学家解释复杂的癌症数据,以改善临床决策.
科学领域:
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
- 癌症基因组学 癌症基因组学
背景情况:
- 癌症基因组图谱 (TCGA) 数据库是一个庞大的资源,由于其规模和数据的多样性,为临床医生和生物学家带来了挑战.
- 有效的可视化工具对于将大数据转化为可操作的临床见解至关重要,特别是在实时解释复杂模式时.
研究的目的:
- 开发TCGAnalyzeR,这是一个免费和高效的Web应用程序,用于TCGA多omics数据的整合可视化和分析.
- 促进临床医生和生物学家利用TCGA数据,以加强癌症研究和临床决策.
主要方法:
- 重新分析了来自33种癌症患者的11000名癌症患者的5种分子数据类型 (突变,转录组,复制数变异,miRNA,甲基化).
- 从文献中整合现有的TCGA患者队伍,并在TCGAnalyzeR.中开发新的可视化模块.
- 实现先进的分析功能,包括驱动器预测,路径分析,生存分析和患者聚类.
主要成果:
- TCGAnalyzeR提供了一个集成的平台,用于可视化预先分析的TCGA数据,其中包含模块用于变异,副本数量更改,差异表达和临床数据.
- 该应用程序可实现以队列为中心或基因为中心的结果的交互可视化,允许用户创建和比较自定义子队列与外部和内部患者集群.
- 整合了多omics,泛癌TCGA数据与来自文献和R包的~120个精选的子队列 (精选TCGAData,BiocOncoTK).
结论:
- TCGAnalyzeR提供了一个强大的,用户友好的解决方案,用于导航和解释TCGA多omics数据的复杂性.
- 该网络应用程序使研究人员和临床医生能够从癌症基因组学数据中获得更深入的见解,支持个性化医学方法.
- TCGAnalyzeR提高了TCGA的可访问性和实用性,促进了癌症研究和治疗策略的进步.
更多相关视频
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.7K
相关概念视频
Cancer Survival Analysis
353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
